Additional file 2: of Interleukin-1 alpha increases anti-tumor efficacy of cetuximab in head and neck squamous cell carcinoma

Espinosa-Cotton, Madelyn; Rodman III, Samuel; Ross, Kathleen; Jensen, Isaac; Sangodeyi-Miller, Kenley; McLaren, Ayana; Dahl, Rachel; Gibson-Corley, Katherine; Koch, Adam; Fu, Yang-Xin; Badovinac, Vladimir; Laux, Douglas; Narasimhan, Balaji; Simons, Andrean

doi:10.6084/m9.figshare.7867115.v1

40425_2019_550_MOESM2_ESM.pptx (113.76 kB)

Additional file 2: of Interleukin-1 alpha increases anti-tumor efficacy of cetuximab in head and neck squamous cell carcinoma

presentation

posted on 2019-03-19, 05:00 authored by Madelyn Espinosa-Cotton, Samuel Rodman III, Kathleen Ross, Isaac Jensen, Kenley Sangodeyi-Miller, Ayana McLaren, Rachel Dahl, Katherine Gibson-Corley, Adam Koch, Yang-Xin Fu, Vladimir Badovinac, Douglas Laux, Balaji Narasimhan, Andrean Simons

Figure S1. Cal-27 tumor responses to anakinra differs by gender. (PPTX 113 kb)

Funding

National Institute of Dental and Craniofacial Research

History

Usage metrics

Keywords

EGFR Cetuximab Interleukin-1 Anakinra Cytokines Nanoparticle HNSCC Biomarker

Licence

CC BY + CC0

Exports

RefWorks

BibTeX

Ref. manager

Endnote

DataCite

NLM

DC

Additional file 2: of Interleukin-1 alpha increases anti-tumor efficacy of cetuximab in head and neck squamous cell carcinoma

Funding

National Institute of Dental and Craniofacial Research

History

Usage metrics

Categories

Keywords

Licence

Exports